4333-21-5 Usage
Uses
Used in Pharmaceutical Industry:
PTH-L-PROLINE is used as a therapeutic agent for bone disorders, such as osteoporosis and Paget's disease, due to its ability to regulate calcium levels and promote bone development and remodeling.
Used in Oncology:
PTH-L-PROLINE is used as a potential therapeutic agent for cancer treatment, particularly in bone metastasis, as it can regulate calcium levels and affect cell proliferation, differentiation, and apoptosis.
Used in Research:
PTH-L-PROLINE is used as a research tool to study the molecular mechanisms underlying calcium homeostasis, bone metabolism, and the physiological processes of cell proliferation, differentiation, and apoptosis. This helps in understanding and developing new therapeutic strategies for related diseases.
Used in Diagnostics:
PTH-L-PROLINE can be used as a biomarker for monitoring calcium levels and bone metabolism in various conditions, aiding in the diagnosis and management of diseases related to bone and mineral homeostasis.
Check Digit Verification of cas no
The CAS Registry Mumber 4333-21-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,3 and 3 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 4333-21:
(6*4)+(5*3)+(4*3)+(3*3)+(2*2)+(1*1)=65
65 % 10 = 5
So 4333-21-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H12N2OS/c15-11-10-7-4-8-13(10)12(16)14(11)9-5-2-1-3-6-9/h1-3,5-6,10H,4,7-8H2
4333-21-5Relevant academic research and scientific papers
Method for treating nerve injury caused as a result of surgery
-
, (2008/06/13)
The present invention relates generally to methods for treating or preventing nerve injury in a warm-blooded animal caused as a consequence of surgery by administering neurotrophic compounds described below. The invention relates more specifically to methods for treating or preventing nerve injury caused as a consequence of prostate surgery as well as erectile dysfunction.
Hydantoin derivative compounds, pharmace utical compositions, and methods of using same
-
, (2008/06/13)
The present invention relates generally to novel hydantoin derivative compounds, pharmaceutical compositions containing such compounds, and methods for their use in preventing and/or treating neurological disorders, including physically damaged nerves and neurodegenerative diseases; for treating alopecia and promoting hair growth; for treating vision disorders and/or improving vision; for treating memory impairment and/or enhancing memory performance; and for treating sensorineural hearing loss by administering such compounds.
